An Insight to ncovid-19 associated coagulopathy

Area of Science:

• Hematology
• Infectious Diseases
• Critical Care Medicine

Background:

• nCOVID-19 infection is associated with a high incidence of coagulopathy.
• Hypercoagulability, microangiopathy, and thrombosis are common in severe nCOVID-19.
• Disseminated intravascular coagulation (DIC)-like syndromes occur in critically ill patients.

Purpose of the Study:

• To review the mechanisms of coagulopathy in nCOVID-19.
• To discuss associated thrombotic and thromboembolic complications.
• To provide information on potential therapeutic strategies.

Main Methods:

• Review of current literature on nCOVID-19 and coagulopathy.
• Analysis of clinical presentations and laboratory findings.
• Synthesis of information on hemostatic biomarkers and thrombotic events.

Main Results:

• nCOVID-19-associated coagulopathy primarily manifests as organ dysfunction.
• Elevated D-dimer and fibrin degradation products indicate massive fibrin formation.
• Increased venous and arterial thrombotic events are observed, particularly in ICU patients.

Conclusions:

• Coagulation tests may help identify severe nCOVID-19 cases.
• Routine thromboprophylaxis with low molecular weight heparin is recommended for hospitalized patients.
• Understanding and managing thromboembolic impediments is critical in nCOVID-19 care.